Multiple Sclerosis Forums

Join us for engaging discussions on 🔥 topics in #multiplesclerosis - earn 🆓#CME with us! #MSoCME #ForuMS

[Multiple Sclerosis Forums @NeuroForuMS]

What a great conversation. Thanks @drbarrysinger & @AaronBosterMD #MSforum

Missed them live? Not too late to chime in:

1⃣ https://t.co/vk9gBGRZMh
2⃣ https://t.co/ZuRZhk5jvH
3⃣ https://t.co/nhxZqkFXkB

[Aaron Boster MD @AaronBosterMD]

🙏🙏 Thank you for joining @drbarrysinger & I for this #MSforum. Your participation and insight have been invaluable! For more medical education programs on Twitter like this, follow @NeuroForuMS ‼️

[Dr. Brandon Beaber @Brandon_Beaber]

10 Ways to Walk Better with Multiple Sclerosis https://t.co/vnS7Guahw1

[Sleep Insights @SleepWellCME]

#SleepInsights livestream w/ @drkoriascher, @sleepdoc5, & Dr Michael Thorpy

🗨️Recognizing & Dx EDS in OSA

#CME🔗 https://t.co/K67uaw6vRd
✍️ Pretest https://t.co/b9SCvvpHcp
🚨 Claim credit https://t.co/T76fGjlnEI

Supported by Jazz Pharmaceuticals, Inc.
https://t.co/qXnJJ0QICt

[Multiple Sclerosis Forums @NeuroForuMS]

📢📢 #NeuroTwitter #MedTwitter

Missed the #MSforum w/ @AaronBosterMD & @drbarrysinger last Wednesday?

Catch up here & 🗣️ your input 👇👇👇

Q1: https://t.co/QbTA7J5Cj2
Q2: https://t.co/ZDSD2FM6uC
Q3: https://t.co/yv7QOhzlQE

[Aaron Boster MD @AaronBosterMD]

A1: 🚨 POLL 🚨

Which of the following factors typically ranks highest after efficacy & safety among your patients w/ regard to treatment selection? #MSforum

[Aaron Boster MD @AaronBosterMD]

A1: 🚨 POLL 🚨

Recent evidence suggests that initiation of high-efficacy therapy during what time frame is associated w/ less disability in patients w/ MS? #MSforum

[Aaron Boster MD @AaronBosterMD]

A2: 🚨 Roll call! What’s your specialty? 🚨 #MSforum

[Multiple Sclerosis Forums @NeuroForuMS]

Last question for the night! #MSforum

[Aaron Boster MD @AaronBosterMD]

One last question before @drbarrysinger & I wrap up this #MSforum

Q3: There is currently a lot of concern about the impact of DMT use on the risk for #COVID19 infection. Has the pandemic changed your approach to how you select a DMT for a given patient, & if so, how?

[Multiple Sclerosis Forums @NeuroForuMS]

Q2: Safety and efficacy are not the only factors to consider when selecting a personalized treatment for patients w/ #MS

✍️ your thoughts & #⃣ #MSforum - We want to hear from you!

[Aaron Boster MD @AaronBosterMD]

👋 #MSforum - Another question ‼️

Q2: In addition to efficacy & safety, what other patient factors are important to take into account when selecting a treatment?

[Multiple Sclerosis Forums @NeuroForuMS]

Q1⃣ ‼️‼️ #MSforum

How do you determine risk and individualize treatment selection based on risk?

[Aaron Boster MD @AaronBosterMD]

Let’s get started!
Q1: Patient risk for future disease activity is a key determinant in DMT selection for patients w/ #MS. How do you determine a patient’s level of risk & how does that then influence your selection of treatment? #MSforum

[Multiple Sclerosis Forums @NeuroForuMS]

@HelenCheung9 @AaronBosterMD @drbarrysinger No. It is all in Twitter via tweets. You can follow the chat on Twitter by going to🔎 search and typing in #MSforum, then going to the latest tab. If you continue to refresh once you are in #MSforum, latest, you will be able to see the latest in the convo.

[Multiple Sclerosis Forums @NeuroForuMS]

We are LIVE! Follow #MSforum and go to latest tab. Refresh to keep up-to-date on the latest in the discussion! @MustStopMS @MSViewsandNews @NerdyNeuroMD @KlausSchmierer

[Aaron Boster MD @AaronBosterMD]

👋 #medtwitter! Thanks for joining @drbarrysinger & I for our #MSforum!

We're going to discuss 3⃣ 🔑 topics related to #MS. Use #MSforum to join the convo & follow along.

Supported by an educational grant from Biogen.

🌟 Info & Pretest 🔗 https://t.co/VXM9Yvhi8x 🌟

[Multiple Sclerosis Forums @NeuroForuMS]

🚨 HAPPENING TONIGHT! 🚨

🧠 Risk assessment, early intervention, and personalizing #MS treatment w/ @AaronBosterMD & @drbarrysinger

🗣️ Tune in by following #MSforum at 8:15 PM ET - Join the discussion ‼️

[Multiple Sclerosis Forums @NeuroForuMS]

21/
That's a wrap! 🎀 Stay tuned for our upcoming LIVE Twitter chat w/ @AaronBosterMD @drbarrysinger ‼️

🗓️ Wednesday, December 8, 2021
⏲️ 8:15 PM - 9:15 PM (ET)
📲 Join the convo w/ #MSforum

[Integrity CE, LLC @IntegrityCE]

It's #TipTuesday!

Did you know you could earn your CME credits online?

🆓Free
📲Convenient
🧠Engaging

@IntegrityCE offers a variety of online CME courses, including some right here on Twitter!

To learn more, visit https://t.co/3wzVndczRJ & follow @SoMeCME!

[Multiple Sclerosis Forums @NeuroForuMS]

📢 2 DAYS AWAY 📢

📅 Wednesday, December 8, 2021
🕗 8:15 - 9:15 PM EST
#⃣ #MSforum

Join Drs. Boster (@AaronBosterMD) & Singer (@drbarrysinger) as they discuss:
💥 Risk assessment
💥 Early intervention
💥 Personalizing #MS treatment during #COVID19

[Sleep Insights @SleepWellCME]

📢 #MedTwitter - We have some exciting news ‼️ 📢

📰 FIRST EVER 🆓 #CME #Tweetorial series
✍️ Burden, Diagnosis & Treatment of #EDS in #OSA
🚀 Launches in 2 weeks!
📲 Right here on @SleepWellCME's Twitter!
🥼🩺 @drkoriascher @sleepdoc5
👥 @justbreathemia

#MedEd #FOAMed

[Multiple Sclerosis Forums @NeuroForuMS]

👋 Happy Thanksgiving!

🙏 #Thankful for the #mscommunity on Twitter
😆 Excited to continue providing #MS education 📚for you all #gratitude #wehaveMS ‼️

@AaronBosterMD @drbarrysinger @NerdyNeuroMD @KlausSchmierer @SKriegerMD @themsguide @MSViewsandNews @MustStopMS

[Multiple Sclerosis Forums @NeuroForuMS]

21/
That's a wrap! 🎀 Stay tuned for our upcoming LIVE Twitter chat w/ @AaronBosterMD @drbarrysinger ‼️

🗓️ Wednesday, December 8, 2021
⏲️ 8:15 PM - 9:15 PM (ET)
📲 Join the convo w/ #MSforum

[Multiple Sclerosis Forums @NeuroForuMS]

1/
📢 #MedTwitter #NeuroTwitter 🆓 #CME:

Check out our FINAL #tweetorial in this #MS series on management of #SPMS w/ @AaronBosterMD & @drbarrysinger

Supported by an educational grant from Biogen.

CME info/Pretest👉https://t.co/zps7b5cCpJ

📌 What’s your specialty ❓

[Multiple Sclerosis Forums @NeuroForuMS]

20/
Posttest Poll 3⃣
🤔 Recent evidence indicates that high-efficacy therapy reduces relapses in which of the following patient SPMS populations ❓